FDA authorizes Novavax’s COVID-19 vaccine for adults 18 and older


Novavax Inc.

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: Horace Mann stock falls on reduced forecast
Next articleFA Center: Don’t fear the bear. It gives you chances to pick winning stocks and beat the market.


Please enter your comment!
Please enter your name here